Satas G, Myers M, McPherson A, Shah S
bioRxiv. 2025; .
PMID: 40060559
PMC: 11888314.
DOI: 10.1101/2025.02.24.639589.
Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F
Nature. 2025; .
PMID: 40044861
DOI: 10.1038/s41586-025-08671-2.
Berg S, Berg J
Front Immunol. 2025; 15:1493978.
PMID: 39981299
PMC: 11840190.
DOI: 10.3389/fimmu.2024.1493978.
Guzelsoy G, Elorza S, Ros M, Schachtner L, Hayashi M, Hobson-Gutierrez S
Nature. 2025; .
PMID: 39972131
DOI: 10.1038/s41586-025-08588-w.
Stone T, Pickles J, Ogunbiyi O, Yasin S, Taylor C, Ahmed S
Acta Neuropathol Commun. 2025; 13(1):30.
PMID: 39948623
PMC: 11823165.
DOI: 10.1186/s40478-024-01922-9.
Single-cell copy number calling and event history reconstruction.
Kuipers J, Tuncel M, Ferreira P, Jahn K, Beerenwinkel N
Bioinformatics. 2025; 41(3).
PMID: 39946094
PMC: 11897432.
DOI: 10.1093/bioinformatics/btaf072.
Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis.
Ma L, Pang Z, Zhang H, Yang X, Zheng S, Chen Y
Proc Natl Acad Sci U S A. 2025; 122(7):e2415244122.
PMID: 39937856
PMC: 11848426.
DOI: 10.1073/pnas.2415244122.
Hormone and HER2-receptor status in breast cancer: determination using sonographically guided core needle biopsy and correlation with excision specimen-a German single institution diagnostic accuracy study.
Pruss M, Cieslik J, Torok J, Dobrowolski J, Neubacher M, Helbig M
Arch Gynecol Obstet. 2025; .
PMID: 39912929
DOI: 10.1007/s00404-024-07920-5.
Discovery of a sushi domain-containing protein 2-positive phenotype in circulating tumor cells of metastatic breast cancer patients.
Bartkowiak K, Mohammadi P, Nissen P, Werner S, Agorku D, Andreas A
Sci Rep. 2025; 15(1):3913.
PMID: 39890941
PMC: 11785953.
DOI: 10.1038/s41598-025-87122-4.
Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives.
Khosroabadi Z, Azaryar S, Dianat-Moghadam H, Amoozgar Z, Sharifi M
Mol Med. 2025; 31(1):33.
PMID: 39885388
PMC: 11783831.
DOI: 10.1186/s10020-025-01085-w.
Hypoxia-Induced Reactive Oxygen Species: Their Role in Cancer Resistance and Emerging Therapies to Overcome It.
Mendoza E, Ciriolo M, Ciccarone F
Antioxidants (Basel). 2025; 14(1).
PMID: 39857427
PMC: 11762716.
DOI: 10.3390/antiox14010094.
TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states.
Panzeri I, Fagnocchi L, Apostle S, Tompkins M, Wolfrum E, Madaj Z
Nat Cancer. 2025; 6(2):385-403.
PMID: 39856421
PMC: 11864977.
DOI: 10.1038/s43018-024-00900-3.
Punctuational evolution is pervasive in distal site metastatic colonization.
Butler G, Amend S, Venditti C, Pienta K
Proc Biol Sci. 2025; 292(2039):20242850.
PMID: 39837515
PMC: 11750355.
DOI: 10.1098/rspb.2024.2850.
Computational frameworks transform antagonism to synergy in optimizing combination therapies.
Chen J, Lin A, Jiang A, Qi C, Liu Z, Cheng Q
NPJ Digit Med. 2025; 8(1):44.
PMID: 39828791
PMC: 11743742.
DOI: 10.1038/s41746-025-01435-2.
ADAR1 Promotes the Progression and Temozolomide Resistance of Glioma Through p62-Mediated Selective Autophagy.
Zhang Y, Guo H, Bu J, Wang W, Wang L, Liu Z
CNS Neurosci Ther. 2025; 31(1):e70168.
PMID: 39825637
PMC: 11742087.
DOI: 10.1111/cns.70168.
Predictive and prognostic value of F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.
Jeong H, Ryu J, Jeong J, Han S, Hyung J, Ahn J
Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39806206
DOI: 10.1007/s00259-024-07058-1.
Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.
Song D, Fan G, Chang M
Cancers (Basel). 2025; 17(1.
PMID: 39796702
PMC: 11719598.
DOI: 10.3390/cancers17010074.
Cardiovascular Disease and Cancer: A Dangerous Liaison.
Newman A, Dalman J, Moore K
Arterioscler Thromb Vasc Biol. 2025; 45(3):359-371.
PMID: 39781742
PMC: 11864891.
DOI: 10.1161/ATVBAHA.124.319863.
Orchard: Building large cancer phylogenies using stochastic combinatorial search.
Kulman E, Kuang R, Morris Q
PLoS Comput Biol. 2025; 20(12):e1012653.
PMID: 39775053
PMC: 11723595.
DOI: 10.1371/journal.pcbi.1012653.
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams.
Cosgrove P, Bild A, Dellinger T, Badie B, Portnow J, Nath A
J Clin Med. 2025; 13(24.
PMID: 39768430
PMC: 11677125.
DOI: 10.3390/jcm13247507.